Relispray -Ayurvedic Pain Relief Spray

Indications

• Type 2 diabetes mellitus
• Dyslipidemia
• Metabolic syndrome
• Antioxidant support
• Anti-inflammatory conditions

Dosage

Children: Specific dosing for children should be determined by a healthcare professional based on individual circumstances and clinical guidelines.

Adults: Dosage varies based on formulation and indication. Commonly, 1-6 grams of powdered cinnamon can be used daily, though specific recommendations should be based on clinical guidelines and individual patient needs.

Mechanism of action

Cinnamon exerts its effects primarily through the modulation of insulin signaling pathways. Cinnamaldehyde enhances insulin sensitivity and may stimulate glucose uptake by cells. It also has antioxidant properties, which help in reducing oxidative stress. Additionally, components of cinnamon may inhibit enzymes involved in carbohydrate digestion, leading to a reduction in postprandial blood glucose levels.

Pharmacodynamics

Cinnamon demonstrates several pharmacodynamic effects, including anti-inflammatory, antioxidant, and antimicrobial activities. Its active compounds can help regulate blood glucose levels, improve lipid profiles by reducing triglycerides and LDL cholesterol, and exhibit potential benefits in metabolic syndrome and type 2 diabetes management.

Pharmacokinetics

The bioavailability of cinnamon compounds varies, but cinnamaldehyde is rapidly absorbed and metabolized in the liver. Its metabolites can be detected in plasma, and the half-life varies based on the dose and formulation. The onset of action for cinnamon extract may vary, and continuous consumption is often required to achieve significant clinical effects. Cinnamon is generally well-tolerated, with minimal adverse effects reported.

Adverse effects

• Allergic reactions
• Gastrointestinal discomfort
• Liver toxicity (with excessive consumption of Cassia cinnamon)

Precautions

• High doses may cause liver damage due to coumarin content in Cassia cinnamon.
• Caution in individuals with liver disease.

Pregnancy

Cinnamon is generally considered safe in food amounts during pregnancy, but high doses should be avoided.

Breast-feeding

Cinnamon is likely safe in food amounts while breastfeeding, but excessive use should be avoided.

Storage

Store in a cool, dry place away from direct sunlight.

Formulations

• Ground cinnamon
• Cinnamon sticks
• Cinnamon oil
• Cinnamon extract

Indications

• Topical analgesia for muscle and joint pain
• Relief of itching from insect bites
• Treatment of minor burns and scrapes
• Symptomatic relief of respiratory conditions when inhaled

Dosage

Children: For children, consult the specific product guidelines and refer to the BNF for Children for appropriate dosing based on age and body weight.

Adults: For topical use, apply a thin layer to the affected area no more than 3 to 4 times daily, depending on the formulation and specific instructions provided.

Mechanism of action

Karpura acts by stimulating the sensory nerve endings in the skin, leading to a cooling sensation that can alleviate pain and itchiness. It is believed to activate TRPM8 receptors, which are responsible for the sensation of coolness. This mechanism contributes to its analgesic effects and helps in reducing inflammation and irritation in localized areas.

Pharmacodynamics

The pharmacodynamic effects of karpura include local anesthetic properties, which provide relief from pain upon topical application. It also exhibits anti-inflammatory effects by modulating the release of pro-inflammatory mediators. Additionally, karpura can enhance blood flow to the affected area, promoting healing and reducing swelling.

Pharmacokinetics

Karpura is absorbed through the skin when applied topically, and its effects can be localized to the area of application. The metabolism of camphor occurs primarily in the liver, where it is converted into metabolites that are then excreted via urine. The onset of action is typically rapid due to its quick absorption, but the duration of effect can vary depending on the formulation and site of application.

Adverse effects

• Skin irritation
• Allergic reactions
• Nausea
• Headache
• Dizziness

Precautions

• Use with caution in patients with a history of hypersensitivity
• Avoid contact with eyes
• Not for consumption

Pregnancy

Safety in pregnancy has not been established; use only if potential benefits justify the risks.

Breast-feeding

Consult a healthcare provider before use while breastfeeding.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Formulations

• Topical ointment
• Cream
• Liquid

Indications

• Respiratory infections
• Bronchitis
• Sinusitis
• Cough
• Pain relief in inflammatory conditions

Dosage

Children: Refer to established guidelines for specific indications and formulations, as doses can vary widely based on the condition treated and the preparation used.

Adults: Refer to established guidelines for specific indications and formulations, as doses can vary widely based on the condition treated and the preparation used.

Mechanism of action

The primary active component of nilgiri, eucalyptol, exhibits mucolytic and anti-inflammatory effects. It acts by stimulating the production of respiratory secretions, thus facilitating the clearance of mucus from the airways. Eucalyptol also possesses antimicrobial properties, which can help reduce infections in respiratory conditions. Additionally, it may have analgesic effects, contributing to pain relief.

Pharmacodynamics

Nilgiri oil, primarily through its main constituent eucalyptol, exerts its effects by interacting with the mucous membranes of the respiratory tract, enhancing mucociliary clearance and reducing inflammation. Its antimicrobial action helps to combat pathogens in respiratory infections, while its analgesic properties may help alleviate discomfort associated with respiratory diseases or inflammation.

Pharmacokinetics

Eucalyptol is rapidly absorbed when inhaled or applied topically. It undergoes extensive metabolism in the liver, primarily through cytochrome P450 enzymes. The elimination half-life of eucalyptol is relatively short, and it is excreted mainly in the urine. The pharmacokinetic profile can vary based on the route of administration and individual patient factors.

Pregnancy

Insufficient data is available to determine the safety of nilgiri during pregnancy. Caution is advised.

Breast-feeding

Limited information is available regarding nilgiri excretion in breast milk. Caution is recommended when using nilgiri while breastfeeding.

Storage

Store in a cool, dry place away from direct sunlight and moisture.

Indications

• Anti-inflammatory
• Analgesic
• Antioxidant
• Traditional medicine uses

Dosage

Children: Refer to established guidelines or consult a healthcare professional for appropriate dosing, as specific pediatric dosing information is not available.

Adults: Refer to established guidelines or consult a healthcare professional for appropriate dosing, as specific dosing information is not available.

Mechanism of action

Phool is thought to exert its effects through multiple pathways, including the modulation of inflammatory mediators and scavenging of free radicals. The specific active compounds within phool may interact with various receptors and signaling pathways, contributing to its therapeutic effects.

Pharmacodynamics

The pharmacodynamics of phool are characterized by its ability to influence various biological processes, including reducing inflammation and pain. Its antioxidant properties may help mitigate oxidative stress in cells, promoting overall health. The exact dose-response relationship and therapeutic window are not well established, necessitating careful monitoring in clinical use.

Pharmacokinetics

The pharmacokinetics of phool, including its absorption, distribution, metabolism, and excretion, are not thoroughly characterized. However, it is typically assumed that the bioactive components are absorbed through the gastrointestinal tract, with potential hepatic metabolism. The half-life and clearance rates have not been definitively established, highlighting the need for further pharmacokinetic studies.

Pregnancy

Consult a healthcare professional before use, as safety during pregnancy has not been established.

Breast-feeding

Consult a healthcare professional before use, as safety during breastfeeding has not been established.

Storage

Store in a cool, dry place away from direct sunlight.

Indications

• Digestive discomfort
• Irritable bowel syndrome
• Nausea
• Headaches
• Respiratory congestion

Dosage

Children: Pediatric dosing for pudinah should be approached with caution. It is advisable to refer to the BNF for Children for specific age-appropriate formulations and doses.

Adults: Dosage varies depending on the form of pudinah. For oral use, peppermint oil may be taken in doses of 0.2 to 0.4 mL, three times daily for digestive issues. For topical applications, dilute peppermint oil in a carrier oil as directed. Consult specific guidelines for proper use.

Mechanism of action

The primary active component of pudinah, menthol, interacts with the TRPM8 (transient receptor potential cation channel subfamily M member 8) receptor, which is involved in sensing temperature and menthol's cooling sensation. This interaction can lead to a sensation of cooling and analgesia, contributing to its use in alleviating symptoms of digestive discomfort and respiratory congestion.

Pharmacodynamics

Pudinah exhibits several pharmacodynamic effects, including antispasmodic properties, which can help relax the smooth muscles of the gastrointestinal tract, thereby reducing symptoms of indigestion and bloating. Additionally, its menthol component has mild analgesic effects, providing relief from headaches and muscle pain when applied topically.

Pharmacokinetics

After ingestion, the active components of pudinah are absorbed in the gastrointestinal tract. The metabolism of menthol primarily occurs in the liver, where it is conjugated and subsequently excreted via urine. The onset of action varies depending on the form of administration, with topical applications providing quicker local relief compared to oral ingestion, which may take longer to exert its effects.

Adverse effects

• Allergic reactions
• Gastrointestinal disturbances
• Heartburn
• Dry mouth

Precautions

• Use with caution in patients with gastroesophageal reflux disease (GERD)
• May enhance the effects of certain medications that affect the gastrointestinal system

Pregnancy

Pudina (peppermint) is generally considered safe when used in food amounts during pregnancy. However, high doses should be avoided due to potential effects on uterine contractions.

Breast-feeding

Pudina is likely safe during breastfeeding when consumed in food amounts. Consult a healthcare provider for higher doses.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Formulations

• Dried leaves
• Essential oil
• Tea

Indications

• Local antiseptic
• Irritant for mucous membranes
• Traditional medicinal uses

Dosage

Children: Refer to established guidelines and clinical practice for specific dosages, as turpentine is not commonly used in modern medicine.

Adults: Refer to established guidelines and clinical practice for specific dosages, as turpentine is not commonly used in modern medicine.

Mechanism of action

Turpentine acts as a local irritant, leading to increased blood flow and inflammatory response in tissues. It may also exert some antimicrobial effects, although the exact pathways are not well defined. The main active components are terpenes, which can affect cellular membranes and interfere with microbial function.

Pharmacodynamics

Turpentine exhibits irritant properties, resulting in stimulation of sensory nerves and local inflammatory responses. It may also have some systemic effects when absorbed, which can lead to toxicity if ingested or inhaled in large amounts. The pharmacological effects are primarily due to its terpene content, which can impact various biological pathways.

Pharmacokinetics

Turpentine is rapidly absorbed through mucous membranes and skin. It is metabolized in the liver, where it undergoes oxidation and conjugation. The metabolites are primarily excreted via the urine. Due to its volatile nature, turpentine can also be inhaled, leading to rapid absorption into the bloodstream. The half-life of turpentine varies based on the method of exposure and individual metabolism.

Contra-indications

• Hypersensitivity to turpentine or any component of the formulation
• Pregnancy and lactation due to potential harmful effects

Adverse effects

• Skin irritation or dermatitis upon topical application
• Gastrointestinal disturbances such as nausea, vomiting, and diarrhea
• Respiratory irritation from inhalation
• Central nervous system effects including headache, dizziness, and confusion
• Kidney damage with prolonged exposure or high doses

Interactions

• May interact with other CNS depressants, increasing sedation
• Potentially enhances the effects of certain medications metabolized by the liver

Precautions

• Use with caution in individuals with pre-existing respiratory conditions
• Should not be ingested or applied to broken skin
• Avoid inhalation of vapors

Pregnancy

Not recommended. Potentially harmful effects on the fetus have been reported.

Breast-feeding

Not recommended. Potential for excretion in breast milk and harmful effects on the infant.

Storage

Store in a cool, dry place away from light, and keep tightly closed. Keep out of reach of children.

Formulations

• Topical ointments or liniments
• Inhalation solutions
• Oral preparations (not commonly recommended due to toxicity)

Indications

• Musculoskeletal pain
• Arthritis
• Tendinitis
• Back pain
• Muscle strains and sprains

Dosage

Children: Refer to the BNF for Children for specific dosing guidelines.

Adults: Apply to the affected area, usually 3 to 4 times daily as needed, ensuring not to exceed the recommended amount.

Mechanism of action

Counter-irritation is thought to be effective at alleviating musculoskeletal pain as the irritation of the sensory nerve endings alters or offsets pain in the underlying muscle or joints served by the same nerves. When applied topically, methyl salicylate penetrates the skin and underlying tissues, where it reversibly inhibits cyclooxygenase enzyme and prevents the production of inflammatory mediators such as prostaglandin and thromboxane A2.

Pharmacodynamics

Methyl salicylate relieves musculoskeletal pain in muscles, joints, and tendons by causing irritation and reddening of the skin due to dilated capillaries and increased blood flow. It acts as a rubefacient and skin irritant, providing a soothing sensation of warmth. Its pharmacological profile is similar to that of aspirin and other NSAIDs.

Pharmacokinetics

Methyl salicylate is absorbed through the skin upon topical application, where it exerts its effects locally. It undergoes metabolism primarily in the liver, and its metabolites are excreted via urine. The onset of action is relatively rapid, given the local application.

Adverse effects

• Skin irritation
• Allergic reactions
• Burning sensation at the application site

Precautions

• Avoid contact with eyes and mucous membranes
• Do not apply to broken or irritated skin
• Use with caution in patients with sensitive skin or allergies

Pregnancy

Data on the safety of wintergreen during pregnancy is limited. Consult a healthcare professional before use.

Breast-feeding

Limited data available; consult a healthcare professional before use.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Formulations

• Topical ointment
• Topical gel
• Liniment

Mechanism of action

Counter-irritation is thought to be effective at alleviating musculoskeletal pain as the irritation of the sensory nerve endings is thought to alter or offset pain in the underlying muscle or joints that are served by the same nerves. This is thought to mask the underlying musculoskeletal pain and discomfort. When applied topically, methyl salicylate is thought to penetrate the skin and underlying tissues where it reversibly inhibits cyclooxygenase enzyme and locally and peripherally prevents the production of inflammatory mediators such as prostaglandin and thromboxane A2.

Pharmacodynamics

Methyl salicylate relieve musculoskeletal pain in the muscles, joints, and tendons by causing irritation and reddening of the skin due to dilated capillaries and increased blood flow. It is pharmacologically similar to aspirin and other NSAIDs but as a topical agent it primarily acts as a rubefacient and skin irritant. Counter-irritation is believed to cause a soothing sensation of warmth.